[3] Her main areas of research currently are into interactions between maternal Killer-cell Immunoglobulin-like Receptor (KIR) and fetal HLA-C molecules, the culture of human trophoblast cells and the link between KIR/HLA-C variants to pre-eclampsia, puerperal sepsis and obstructed labour.
These artificial placenta organoids provide an additional tool for research into placental development and the effects of hormones, drugs, and infection such as Zika virus.
[7] Moffett has come out strongly against the use of immune-suppressive drugs as a means of preventing miscarriage, commenting, "That's a very attractive idea, but it's actually not correct.
"[8] Also, in relation to pregnancy, she has stated that pre-eclampsia, often experienced by African women, is impossible to predict or prevent.
"Even when it is detected the only course of action is constant monitoring, and ultimately the only cure is delivery – sometimes at too early a stage for the baby to survive.